PF-Atlas › Clinical Trials › NCT01460836
Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis
Tobramycin solution for inhalation · Not specified
Registry ID
NCT01460836
Phase
Not specified
Status
Completed
Drug / intervention
Tobramycin solution for inhalation
Sponsor
Novartis Pharmaceuticals
Start
2010-04
About this trial
Matching-adjusted indirect comparison of tobramycin solution (TIS) versus aztreonam lysine (AZLI) using TIS patient level clinical trial data and AZLI aggregated clinical trial data from published literature.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT01460836 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.